Navigation Links
Argos Therapeutics' Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
Date:6/1/2011

Marathovouniotis
Russo Partners LLC
(212) 845-4271 or (212) 845-4235
david.schull@russopartnersllc.com or andreas.marathis@russopartnersllc.com

Jeff Abbey
Argos Therapeutics
(919) 287-6308
jabbey@argostherapeutics.com


'/>"/>
SOURCE Argos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial
2. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
3. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
4. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
5. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
6. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
7. Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017
8. Reportlinker Adds Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
9. Cell Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Rule
10. Amicus Therapeutics to Present at Jefferies 2011 Global Healthcare Conference on Tuesday, June 7, 2011
11. Reportlinker Adds Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
(Date:1/15/2014)... 15, 2014 Tegra Medical is very pleased to announce ... its new Chief Executive Officer.  Mark was promoted from his ... overseen the company,s four facilities in Massachusetts ... King joined Tegra Medical in 2012 with 20+ years of ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Bacterin International Holdings, Inc. (NYSE Amex: ... of revolutionary bone graft material and antimicrobial coatings for ... American Medical Concepts (AMC), the largest multi-specialty Orthopedic, Spine ... the U.S. The award gives Bacterin ,pre-approved, ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... (FDA) has scheduled a meeting of the Psychopharmacologic Drugs ... the ADASUVE New Drug Application (NDA) will be discussed. ... had accepted the resubmission of the ADASUVE NDA and ...
Cached Medicine Technology:Bacterin Awarded Approved Vendor Status for American Medical Concepts' Network of Hospitals in the Northwest U.S. 2Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011 2Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011 3
(Date:4/24/2014)... at UT Southwestern Medical Center previously discovered that the ... adult heart lacks this ability. New research by the ... its incredible regenerative capability in adulthood, and the answer ... It is well-known that a major function of the ... But at the same time, oxygen is a highly ...
(Date:4/24/2014)... April 24, 2014 ,Take me out to ... slices and kale chips. The more likely culprits include ... , Unfortunately for children who play youth baseball, ... contributing to weight problems, according to researchers at Wake ... current online edition of Childhood Obesity , found ...
(Date:4/24/2014)... in the new Institute for Biomedical Sciences at ... million federal grant to develop novel therapeutics against ... from the Eunice Kennedy Shriver National Institute Of ... Institutes of Health will support Plemper,s drug development ... least one distinct alternative compound. , Infections by ...
(Date:4/24/2014)... national response to the epidemic of prescription opioid overdose ... Journal of Medicine by leaders of agencies in ... The commentary calls upon health care providers to expand ... reduce overdose deaths, and describes a number of misperceptions ... The commentary also discusses how medications can be used ...
(Date:4/24/2014)... researchers was the first in the world to discover ... of the jaw. , Ameloblastoma is an odontogenic tumour ... is most often found in the posterior of the ... in tissue deficiencies in the jaws as well as ... reduce the need for surgery and the recurrence of ...
Breaking Medicine News(10 mins):Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:Take the bat, leave the candy 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4
... The Authority in 2007 developed and began implementing ... in Patient Safety Advisories to,improve patient safety while ... and nursing homes began, HARRISBURG, Pa., April ... 2007 Annual Report today outlining,its Strategic Plan that ...
... EAU Technologies, a leading provider,of Electrolyzed Water - ... announced that Wade Bradley, President and,CEO, will be ... Financial,Conference to be held at the Monterey Plaza ... Bradley will review the company,s corporate strategy, strengths,and ...
... feelings are ,fragile, it,s no better than having a poor ... -- There,s a big difference between "secure" high self-esteem and ... that those with the secure form are less likely to ... self-esteem, and in this study, we found that for those ...
... also available in French . , Contrary ... dont necessarily eat a healthier diet than their less-active ... between body mass index (BMI) values and levels of ... 900 Vancouver-area teenagers in Grades 10 through 12 was ...
... technology enhances the state of health care ... 30 SeQual Technologies Inc., a San,Diego-based ... worldwide for their reliability, quality, revolutionary design ... its new rugged,light-weight, battery operated oxygen concentrator, ...
... Systems,Corporation (NYSE: PER ) today announced ... #1 ranking in the KLAS survey of ... Known throughout,the Healthcare industry for its stringent ... decisions by independently,monitoring vendor performance through the ...
Cached Medicine News:Health News:Patient Safety Authority Issues Annual Report for 2007 2Health News:Patient Safety Authority Issues Annual Report for 2007 3Health News:Patient Safety Authority Issues Annual Report for 2007 4Health News:Patient Safety Authority Issues Annual Report for 2007 5Health News:Patient Safety Authority Issues Annual Report for 2007 6Health News:Patient Safety Authority Issues Annual Report for 2007 7Health News:Patient Safety Authority Issues Annual Report for 2007 8Health News:Patient Safety Authority Issues Annual Report for 2007 9Health News:Patient Safety Authority Issues Annual Report for 2007 10Health News:Patient Safety Authority Issues Annual Report for 2007 11Health News:Patient Safety Authority Issues Annual Report for 2007 12Health News:Patient Safety Authority Issues Annual Report for 2007 13Health News:Patient Safety Authority Issues Annual Report for 2007 14Health News:Patient Safety Authority Issues Annual Report for 2007 15Health News:Patient Safety Authority Issues Annual Report for 2007 16Health News:Patient Safety Authority Issues Annual Report for 2007 17Health News:Patient Safety Authority Issues Annual Report for 2007 18Health News:EAU Technologies to Present at AeA Micro Cap Conference 2Health News:EAU Technologies to Present at AeA Micro Cap Conference 3Health News:High Self-Esteem May Mask Defensiveness 2Health News:Physical activity, healthy eating and BMI not linked in older teens: study 2Health News:US Army Purchases SeQual's Cutting-Edge Oxygen Generation Technology for MRAP Deployment 2Health News:Perot Systems Ranked #1 for Clinical Implementation Services By KLAS 2Health News:Perot Systems Ranked #1 for Clinical Implementation Services By KLAS 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: